All posts by WordPress PHRI.ICT

Virtual – International Collaboration Meeting

Friday September 25, 2020

Co-chairs
Ben Freedman
Emma Svennberg        
CLOSED SESSION FOR AF-SCREEN MEMBERS AND INDUSTRY SUPPORTERS
Zoom Session
Request Password
Ben Freedman Welcome and introduction              
Lena Rivard Dementia and AF Screening White paper
Emma Svennberg      Progress of ongoing large screening studies with hard outcome endpoints
Jeff Healey Meta-analysis and meta-regression of studies with hard endpoints: Status of Prospero Paper
Giuseppe Boriani Survey: wearables/devices and consumer-led screening
Axel Brandes 
Stavros Stavrakis 
Consumer-led AF Screening White paper
Renate Schnabel AF-SCREEN Future Activities and Horizon 2020/AFFECT-EU programme update
Co-Chairs
Jeff Healey
Renate Schnabel                
OPEN SESSION ON AF SCREENING
MP4
4.7 GB download
Ben Freedman Year in Review for AF-SCREEN and Screening for AF
Mike Gibson Heartline study update (Janssen J&J/Bayer/Apple watch)
Søren Diederichsen Simulations from the Danish Loop Study: relevance to other screening methodologies
Peter Noseworthy AI and Machine Learning using eMR, biomarkers and 12-lead ECG to predict AF and AF-related events
Emelia Benjamin What are the research priorities in screening for AF

Thank you to our supportive sponsors:

Munich – Annual Meeting

Saturday, August 25, 2018

Ben Freedman Year in review: Screening for Atrial Fibrillation
Mårten Rosenqvist Update on current and planned outcome studies
Jonathan Mant Status of UK primary care screening study
John Eikelboom Covert AF in Vascular Prevention Trials:  Lessons from COMPASS and NAVIGATE ESUS – [download will be available early 2019]
Barbara Casadei UK Biobank study
Jeff Healey Treatment of subclinical AF
Renate Schnabel
Ben Freedman
Controversies and key points for post-stroke white paper
Mintu Turakhia Testing new AF screening methods at scale – [slides not available – more information is available at this link]
Ben Freedman Future activities and meetings

Munich – HRS Symposia

Thursday May 10, 2018
10:30 am to 12 pm
Ballroom East BCEC

Featured Symposium:  B-013 Contemporary Management of Atrial Fibrillation: Stroke Prevention
A. J. Camm Selection of Oral Anticoagulant Agents for Thromboembolic Prophylaxis in Non-Valvular Atrial Fibrillation
B. Freedman Screening for Asymptomatic AF in the Population (Without Implanted Devices): Where Do We Stand?”
J. S. Healey Subclinical AF Detected By Implanted Devices: Should We Anticoagulate?
H. Calkins Should Oral Anticoagulation Be Discontinued Following AF Ablation?

Munich – ESC Symposia

If you want to add any items to this list, please email cspin.admin@phri.ca

Date Time Title Speaker Location Session
Sat Aug 25 9:00-10:30 AFib – Stroke Prevention Symposium Chaired by M. Ezekowitz, L. Fauchier Madrid Village 6 Symposium
Sun Aug 26 10:05-10:55 AF SMART: Electronic tools and system for atrial fibrillation screening in general practice: automated prompts, electronic decision support and data extraction, all integrated with clinical software J Orchard Exhibition 3 Digital Health Stage
Sun Aug 26 11:45 Identifying the undiagnosed AF patient through ‘Know Your Pulse’ community pharmacy based events held in ten countries during Arrhythmia Alliance World Heart Rhythm Week 2017 N. Breakwell Agora 2 – Agora Rapid Fire Abstract
Sun Aug 26 12:03 Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide – preliminary results from the strokestop 2 study K. Kemp Gudmundsdottir Agora 2 – Agora Rapid Fire Abstract
Sun Aug 26 8:30 – 12:30 A comparison of intermittent and continuous event recording in population screening for atrial fibrillation T. Fredriksson Poster Area Poster Session 2
Sun Aug 26 8:30 – 12:30 Assessment of N-terminal pro-brain natriuretic peptide level in the screening for atrial fibrillation in the primary health care F. Ghazal Poster Area Poster Session 2
Sun Aug 26 8:30 – 12:30 Use of a smartphone electrocardiogram, electronic prompts and electronic decision support for atrial fibrillation screening in metropolitan general practices J. Orchard Poster Area Poster Session 2
Sun Aug 26 8:30 – 12:30 Comparing atrial fibrillation detection algorithms in smart devices on validated mobile ECG data J. Eckstein Poster Area Poster Session 2
Sun Aug 26 14:00 – 18:00 Clinical characteristics of an elderly population with screening-detected elevated NT-proBNP levels without previous diagnosis of heart failure or atrial fibrillation (Substudy of STROKESTOP II) F. Al-Khalili Poster Area Session 3
 
P2797
Mon Aug 27 8.30-10.00 Handheld ECG devices for the detection of atrial fibrillation – State of the art N. Lowres Digital Health Stage- Exhibition 3 Chronic nursing care symposium
Mon Aug 27 8.30-10.00 Handheld ECG devices for the detection of atrial fibrillation – The role of the nurse and allied health professionals. L. Neubeck Digital Health Stage- Exhibition 3 Chronic nursing care symposium
Mon Aug 27 08:30 – 10:00 AFib – The “Big Picture” Chaired by R. Schilling, C. Blomstrom-Lundqvist Madrid Village 6 Special Session
Mon Aug 27 11:00 Screening for atrial fibrillation:  modern alternatives L. Neubeck Madrid Village 6 Chronic nursing care symposium
Mon Aug 27 13:00 – 14:00 Spectrum of non-valvular atrial fibrillation: burden of disease Chaired by J. Camm Bratislava – Village 2 Satellite symposium
Mon Aug 27 13:00 Stroke prevention – How broad is the spectrum of atrial fibrillation? J. Camm Bratislava – Village 2 Satellite symposium
Mon Aug 27 13:15 Roadmap for AF detection – Why, where and how to search? B. Freedman Bratislava – Village 2 Satellite symposium
Mon Aug 27 13:55 Panel discussion – Spectrum of non-valvular atrial fibrillation: burden of disease. Chaired by J. Camm, B. Freedman Bratislava – Village 2 Satellite symposium
Tue Aug 28 14:00-18:00 Implementation of screening for atrial fibrillation in general practice with a single-lead ECG: A cluster randomized controlled trial F. Kaasenbrood Poster Area Poster Session 7
Tue Aug 28 14:00-18:00 Pulse palpation and history of palpitations in atrial fibrillation screening – preliminary results from the strokestop 2 study K. Kemp Gudmundsdottir Poster Area Poster Session 7

Rome – Annual Meeting

Session 1

J. Camm Welcome and Introduction to AF-SCREEN
E. Svennberg Single Time Point, Incidental Clinical Detection, Patient Activated
G. Boriani
J. Healey
Continuous Recordings Implanted/External
C. Albert Patients vs Population, Risk Enchancement vs Simple Age Criteria
R. Sandhu Settings to Screen: Community, Pharmacy, Clinic 
M. Rosenqvist Simple Inexpensive Methods Actionable AF 
J. Wang Non USA/Non Europe Perspective

Session 2

R. Schnabel What Size of Study is Required to Impact Guidelines
H. Calkins AHA/ACC/HRS Guidelines
G. Lip ACCP and APSC and NICE Guidelines
B. Freedman Closing Remarks